Rational use of the EAC real-time quantitative PCR protocol in chronic myelogenous leukemia: Report of three false-negative cases at diagnosis [5]

Leukemia

Volumn 20, Issue 5, 2006, Pages 886-888

  Dessars, B ^a   El Housni, H ^a   Lambert, F ^b   Kentos, A ^a   Heimann, P ^a,c  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN;

BONE MARROW BIOPSY; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; LETTER; MINIMAL RESIDUAL DISEASE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROCESS DESIGN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REFERENCE VALUE;

EID: 33646131423     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404174     Document Type: Letter

References (6)

1. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia 2003; 17: 2318-2357.
2. Pane F, Intrieri M, Quintarelli C, Izzo B, Muccioli GC, Salvatore F. BCR/ ABL genes and leukemic phenotype: From molecular mechanisms to clinical correlations. Oncogene 2002; 21: 8652-8667.
3. Sugimoto T, Ijima K, Hisatomi H, Murayama T, Mizuno I, Hato A et al. Second case of CML with aberrant BCR-ABL fusion transcript (e8/a2) with insertion of an inverted ABL intron 1b sequence. Am J Hematol 2004; 77: 164-166.
4. Cross NC, Melo JV, Feng L, Goldman JM. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia 1994; 8: 186-189.
5. van der Velden VH, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, van Dongen JJ. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: Principles, approaches, and laboratory aspects. Leukemia 2003; 17: 1013-1034.
6. Emig M, Saubele S, Wittor H, Weiber A, Reiter A, Willer A et al. Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia 1999; 13: 1825-1832.